COVID cases continue decline across the US though immune evasive Omicron variant dominates
Firn/iStock via Getty Images


The number of weekly COVID cases has been declining since early January, according to data from the CDC.
In 2023, the number of cases peaked the week ending Jan. 4 with 479,562 cases. For the week ended March 1, the figure was 226,618.

The CDC data also indicates that Omicron subvariant XBB.1.5 continues to dominate cases. The subvariant, which is considered immune evasive, accounted for 89.6% of weekly cases as of March 3. The prior week, it accounted for 85.4% of cases.
COVID vaccine makers: Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX), and Novavax (NASDAQ:NVAX).
The encouraging data comes as the US government is preparing to end the public health emergency in May. Perhaps the biggest impact to US residents is that fee-free COVID vaccines, tests, and treatment will come to an end.